Citrotech Inc. (CITR) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Citrotech Inc. (CITR) stock forecast summary
On Oct. 14, 2026, CITR is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 4004 stocks scored that day.
Its market capitalization is not available, so no size classification is given. Its ROE of -247.6% is the lowest of the 10 peers that report one. Its Gross Margin of -4.6% is the lowest of the 14 peers that report one.
A per-ticker accuracy statistic for CITR is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.2%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CITR included.
Follow CITR freeCITR price chart and AI forecast
How CITR ranks among 4004 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Citrotech Inc. (CITR) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Chemicals & Allied Products peers listed below that report each metric.
Valuation & Market
| Metric | CITR | Rank |
|---|---|---|
| EPS | $-3.28 | – |
Profitability & Margins
| Metric | CITR | Rank |
|---|---|---|
| ROE | -247.6% | 10/10 |
| ROA | -222.3% | 11/13 |
| ROIC | -186.8% | 11/11 |
| Gross Margin | -4.6% | 14/14 |
| Operating Margin | -1199.1% | 13/13 |
| Net Margin | -1489.7% | 12/13 |
| EBT Margin | -1611.8% | 14/14 |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | CITR | Rank |
|---|---|---|
| Current Ratio | 8.77x | 2/14 |
| Quick Ratio | 7.39x | 2/13 |
| D/E Ratio | 0.11x | 11/12 |
| Financial Leverage | 1.11x | 11/12 |
| Interest Coverage | -979.0x | 13/14 |
| Working Capital | $3M | 12/14 |
Cash Flow
| Metric | CITR | Rank |
|---|---|---|
| Operating Cash Flow | -$10M | 13/15 |
| Free Cash Flow | -$10M | 9/9 |
| Capital Spending | -$50K | 1/9 |
| FCF/Sales | -732.8% | 9/9 |
| CapEx/Sales | 3.5% | 5/9 |
Operational Efficiency
| Metric | CITR | Rank |
|---|---|---|
| Asset Turnover | 0.13x | 11/13 |
| Receivables Turnover | 8.2x | 2/10 |
| Inventory Turnover | 2.5x | 11/13 |
| Fixed Assets Turnover | 2.8x | 6/13 |
| Days Sales Outstanding | 45 days | 9/10 |
| Days Inventory | 149 days | 3/13 |
| Payables Period | 57 days | 6/10 |
| Cash Conversion Cycle | 137 days | 2/7 |
Income Statement
| Metric | CITR | Rank |
|---|---|---|
| Total Revenue | $1M | 11/13 |
| Operating Income | -$17M | 8/13 |
| Net Income | -$22M | 7/13 |
| R&D Expense | $490K | 9/10 |
| Cost of Goods Sold | $1M | 13/14 |
Dividend & Shareholder Information
| Metric | CITR | Rank |
|---|---|---|
| EPS Growth | -118.0% | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $4M | |
| Cash & Short-term Investments | $3M | |
| Accounts Receivable | $170K | |
| Inventory | $580K | |
| Total Liabilities | $1M | |
| Short-term Debt | $200K |
CITR quarterly financials and insider trading
Citrotech Inc. (CITR) industry peers
Companies classified under the same SEC industry code as Citrotech Inc. (Chemicals & Allied Products): 17 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| CITR Citrotech Inc. | ▶ | N/A |
| BCPC Balchem Corp | ▶ | $5.41B |
| PRM Perimeter Solutions, Inc. | ▲ | $4.50B |
| NGVT Ingevity Corp | ▶ | $2.41B |
| IOSP Innospec Inc. | ▼ | $2.40B |
| CC Chemours Co | ▼ | $1.99B |
| OLN Olin Corp | ▶ | $1.69B |
| HUN Huntsman Corp | ▶ | $1.43B |
| ECVT Ecovyst Inc. | ▲ | $1.09B |
| FMC Fmc Corp | ▶ | $1.04B |
| SLI Standard Lithium Ltd. | ▼ | $343M |
| ADUR Aduro Clean Technologies Inc. | ▶ | $307M |
| ACNT Ascent Industries Co. | ▲ | $122M |
| LQMT Liquidmetal Technologies Inc | ▼ | $83M |
| BLGO Biolargo, Inc. | ▲ | $26M |
| GURE Gulf Resources, Inc. | ▶ | $5M |
| LOOP Loop Industries, Inc. | ▶ | N/A |
Where CITR sits on the market map
Citrotech Inc. (CITR) stock news
Loading...
Citrotech Inc. (CITR) stock forecast FAQ
What is the Citrotech Inc. (CITR) stock forecast?
On Oct. 14, 2026, CITR is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 4004 stocks scored that day.
How accurate are Citrotech Inc. stock predictions?
A per-ticker accuracy statistic for CITR is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Citrotech Inc. forecasts updated?
Citrotech Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Citrotech Inc.'s industry peers?
17 issuers in our coverage, CITR included, share the SEC industry code Chemicals & Allied Products. The largest are: Balchem Corp (BCPC), Perimeter Solutions, Inc. (PRM), Ingevity Corp (NGVT), Innospec Inc. (IOSP), Chemours Co (CC), Olin Corp (OLN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.